Enhanced left ventricular systolic function early in type 2 diabetic mice: Clinical implications

Diabetes & Vascular Disease Research

Volumn 1, Issue 2, 2004, Pages 89-94

  Alvarez, Jorge A ^a   Reyes, Maricela ^a   Escobedo, Daniel ^a   Freeman, Gregory L ^a   Steinhelper, Mark E ^a   Feldman, Marc D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BODY WEIGHT; DISEASE MODEL; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SYSTOLE; TIME;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMIC PROCESSES; MICE; MICE, MUTANT STRAINS; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 33644666330     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2004.013     Document Type: Article

References (21)

1. Devereux RB, Roman MJ, Paranicas M et al. Impact of diabetes on cardiac structure and function. Circulation 2000; 101: 2271–2276.
2. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982; 31: 1–6.
3. Bray GA. The Zucker-fatty rat: a review. Fed Proc 1977; 36: 148–153.
4. Zucker LM, Antoniades HN. Insulin and obesity in the Zucker genetically obese rat “fatty”. Endocrinology 1972; 90: 1320–1326.
5. Giacomelli F, Wiener J. Primary myocardial disease in the diabetic mouse. Lab Invest 1979; 40: 460–473.
6. Crettaz M, Zaninetti D, Jeanrenaud B. Insulin resistance in hearts and skeletal muscle of genetically (fa/fa) rats. Diabetologia 1976; 25: 525–529.
7. Rösen P, Herberg L, Reinauer H, Adrian M, Feuerstein J, Topütt. Different types of postinsulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats. Endocrinology 1986; 119: 1285–1291.
8. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db). mice. Am J Physiol Endocrinol 2000; 279: E1104–E1113.
9. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Heart Physiol 2002; 283: H976–H982.
10. Utriainen T, Takala T, Luotolahti M et al. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 1998; 41: 555–559.
11. Georgakopoulos D, Mitzner WA, Chen CH et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol Heart Circ Physiol 1998; 274: H1416–H1422.
12. Feldman MD, Erikson JM, Mao Y, Korcarz CE, Lang RM, Freeman GL. Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol 2000; 274: H1698–H1707.
13. Baan J, Van der Velde ET, De Bruin HG et al. Continuous measurement of LV volume in animals and humans by conductance catheter. Circulation 1984; 70: 812–823.
14. Geddes L, Hoff H, Mello A, Palmer C. Continuous measurement of ventricular stroke volume by electrical conductance. Cardiovasc Res 1964; 4: 118–130.
15. Reyes M. Importance of genetic background on myocardial frequency-resistivity relationships in mice. University of Texas at San Antonio. Masters Thesis. October 2003.
16. Feldman MD, Mao Y, Valvano JW, Pearace JA, Freeman GL. Development of a multifrequency conductance catheter-based system to determine LV function in mice. Am J Physiol Heart Circ Physiol 2000; 279: H1411–H1420.
17. Chen H, Charlat O, Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491–495.
18. O'Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Seminars Nephrol 1997; 17: 93–100.
19. Frank RN. Diabetic Retinopathy. N Engl J Med 2004; 350(1):48–58.
20. UK Prospective Diabetes Study Group et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.
21. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997; 34: 25–33.